Literature DB >> 6278362

Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients.

A Salmi, B Ziola, T Hovi, M Reunanen.   

Abstract

Multiple sclerosis (MS) and matched control sera had similar antibody titers to coronaviruses OC43 and 229E when tested by a radioimmunoassay method. In contrast, cerebrospinal fluid from MS patients contained coronavirus antibodies more frequently and in higher titers than matched controls. Intrathecal antibody synthesis to OC43 and 229E viruses was detected in 41% (9/22) and 26% (7/27) of MS patients, respectively, but was not found in any of the neurologic control patients. This intrathecal antibody synthesis may mean that coronaviruses play an etiologic or pathogenic role in MS. Alternatively, intrathecal synthesis of coronavirus antibodies may be but part of a generalized and variable intrathecal antibody synthesis that is typical for MS patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6278362     DOI: 10.1212/wnl.32.3.292

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  35 in total

Review 1.  Murine coronavirus infection: a paradigm for virus-induced demyelinating disease.

Authors:  T E Lane; M J Buchmeier
Journal:  Trends Microbiol       Date:  1997-01       Impact factor: 17.079

2.  Neuroinvasion by human respiratory coronaviruses.

Authors:  N Arbour; R Day; J Newcombe; P J Talbot
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

3.  Infection of primary cultures of human neural cells by human coronaviruses 229E and OC43.

Authors:  A Bonavia; N Arbour; V W Yong; P J Talbot
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

4.  Acute and persistent infection of human neural cell lines by human coronavirus OC43.

Authors:  N Arbour; G Côté; C Lachance; M Tardieu; N R Cashman; P J Talbot
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

5.  Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E.

Authors:  N Arbour; S Ekandé; G Côté; C Lachance; F Chagnon; M Tardieu; N R Cashman; P J Talbot
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

6.  In vivo and in vitro models of demyelinating disease. IX. Progression of JHM virus infection in the central nervous system of the rat during overt and asymptomatic phases.

Authors:  O Sorensen; M B Coulter-Mackie; S Puchalski; S Dales
Journal:  Virology       Date:  1984-09       Impact factor: 3.616

7.  Vaccination against lethal coronavirus-induced encephalitis with a synthetic decapeptide homologous to a domain in the predicted peplomer stalk.

Authors:  P J Talbot; G Dionne; M Lacroix
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

8.  Human coronavirus gene expression in the brains of multiple sclerosis patients.

Authors:  J N Stewart; S Mounir; P J Talbot
Journal:  Virology       Date:  1992-11       Impact factor: 3.616

9.  Antigenic characterization of human coronaviruses 229E and OC43 by enzyme-linked immunosorbent assay.

Authors:  O W Schmidt
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

10.  Possible central nervous system infection by SARS coronavirus.

Authors:  Kwok-Kwong Lau; Wai-Cho Yu; Chung-Ming Chu; Suet-Ting Lau; Bun Sheng; Kwok-Yuen Yuen
Journal:  Emerg Infect Dis       Date:  2004-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.